ClinicalTrials.Veeva

Menu

Chronic Obstructive Pulmonary Disease and Pulmonary Hypertension: Prevalence and Quality of Life

W

Wissenschaftliches Institut Bethanien e.V

Status

Completed

Conditions

Hypertension, Pulmonary
Pulmonary Disease, Chronic Obstructive

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT01423071
WI_PH+COPD_73/2011

Details and patient eligibility

About

The purpose of this study is to determine the prevalence of pulmonary hypertension (PH) among patients suffering from Chronic Obstructive Pulmonary Disease (COPD) and to assess the quality of life in those patients with concomitant PH compared to COPD patients without PH and those only suffering from pulmonary arterial hypertension (PAH) respectively.

Enrollment

220 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age ≥ 18 years
  • Known or newly diagnosed COPD or PAH
  • Written informed consent
  • Present long-term oxygen treatment is no exclusion criterion

Exclusion criteria

  • Age < 18 years
  • Right-heart catheterization not reasonable
  • Pregnancy, Lactation
  • Life expectancy <12 months due to any diseases aside from COPD
  • Any medical, psychological or other condition, which limits the patient's ability to provide informed consent
  • No written informed consent provided
  • Current participation in another clinical trial

Trial design

220 participants in 3 patient groups

COPD with PH
Description:
COPD patients with confirmed diagnosis of PH.
COPD without PH
Description:
COPD patients without confirmed diagnosis of PH
PAH without COPD
Description:
PAH patients who do not suffer from COPD

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems